About Wroclaw Medical University
Scientific Excellence
At Wroclaw Medical University, science is at the core of our mission: together we shape the future of medicine. Guided by passion, courage, collaboration, empathy, and integrity, we are committed to advancing medical research with a global impact.
Strategic Goal
The strategic objective of our scientific activity is the development of research that drives progress in medicine and improves health worldwide.
Key Directions
- High-impact research
We continuously increase the number and quality of high-ranking scientific publications, ensuring international visibility and influence. - Interdisciplinary innovation
Our research teams connect medicine, pharmacy, health sciences, biotechnology, bioinformatics, and engineering to address complex health challenges. - Support for young scientists
Through initiatives such as the Academy of Young Scientists, nano-grants, and international mobility programs, we nurture the next generation of researchers. - Collaboration with industry
We work closely with pharmaceutical and biotechnology partners, conducting R&D projects, implementing innovation, and supporting knowledge transfer. - Internationalisation
WMU builds global partnerships, hosts visiting professors, develops joint projects, and promotes mobility of students, PhD candidates, and staff. - Responsible research culture
As a holder of the HR Excellence in Research award, we ensure transparent recruitment, supportive working conditions, and strong ethical standards.
Research at a glance
At Wroclaw Medical University, research is the driving force behind innovation in medicine and healthcare. As one of Poland’s leading research-intensive medical universities, we combine scientific discovery with clinical expertise to address the most pressing challenges in cardiovascular medicine, oncology, population health and translational biomedical sciences.
5,489
Publications
13.2%
Top 10% papers worldwide
1.68
CNCI
326
International clinical trials
26
International clinical guidelines
3.34
CNCI Internationally co-authored publications
Research at WMU is conducted in close collaboration with the University Clinical Hospital, creating an integrated academic medical centre where discoveries move efficiently from laboratory to bedside and back to research. This unique ecosystem enables our scientists to translate fundamental discoveries into improved diagnostics, therapies, clinical guidelines and healthcare solutions that benefit patients worldwide.
Between 2020 and 2024, researchers at Wroclaw Medical University published 5,489 scientific papers indexed in Web of Science.
Our research demonstrates both high quality and international impact:
- 13.2% of publications belong to the world’s Top 10% most cited papers.
- Category Normalized Citation Impact (CNCI): 1.68, indicating that our publications are cited substantially above the global average.
- 37.1% of publications are produced in international collaboration.
- Internationally co-authored publications achieve a CNCI of 3.34, reflecting their exceptional scientific influence.
Our researchers publish regularly in the world’s leading medical journals, including New England Journal of Medicine, The Lancet, Nature Medicine, Circulation, JACC: Heart Failure and European Journal of Heart Failure.
Strategic Research Priorities
Cardiology
From landmark trials to guidelines - advancing heart failure and cardio-renal-metabolic medicine.
Oncology
Leading research in transplantation, immunotherapy and precision medicine for blood cancers.
Population Health, Neuroscience and Psychiatry
Integrating epidemiology, translational neuroscience and data-driven approaches to improve population health.
Pediatrics and rare diseases
Developing innovative diagnostics and therapies for rare and paediatric diseases worldwide.
Research is organised around interdisciplinary Priority Research Areas that bring together clinicians, biomedical scientists, epidemiologists, data scientists and engineers.
Our strategic priorities include:
- Cardio-Renal-Metabolic Medicine – Developing innovative diagnostics and therapies for heart failure, cardiovascular diseases, hypertension, kidney diseases and metabolic disorders, while contributing to international clinical guidelines, landmark clinical trials and precision medicine approaches.
- Hematology, Oncology and Cellular Therapies – Advancing precision medicine, stem cell transplantation, immunotherapy, CAR-T technologies and translational cancer research to improve outcomes for patients with haematological and oncological diseases.
- Population Health and Epidemiology – Generating evidence to improve prevention, public health policies and healthcare systems through epidemiology, demography, digital health, artificial intelligence, metabolomics and the analysis of large-scale health data.
- Pediatrics and Rare Diseases – Advancing innovative diagnostics, genomic medicine and personalised therapies for children and patients with rare diseases through interdisciplinary and translational research aimed at improving outcomes for vulnerable populations.
Research that changes clinical practice
Scientific excellence at WMU extends beyond publications to direct influence on international standards of care.
Between 2020 and 2025, University researchers contributed to:
- 26 international clinical guidelines
- cited more than 22,000 times
including key recommendations published by the European Society of Cardiology (ESC) covering heart failure, cardiovascular prevention, hypertension, acute coronary syndromes and cardiovascular diseases during pregnancy.
Researchers also co-authored 326 international clinical trial publications, which have generated over 25,900 citations, confirming the University’s active participation in studies that shape contemporary clinical practice.
Among the most influential international projects are:
- EMPEROR-Reduced
- EMPEROR-Preserved
- VICTORIA
- AFFIRM-AHF
whose findings have been incorporated into international treatment recommendations.
Innovation through collaboration
Scientific progress at WMU is driven by interdisciplinary collaboration across medicine, pharmacy, dentistry, health sciences, molecular biology, biotechnology, bioinformatics and engineering.
Our researchers work within international consortia, collaborate with pharmaceutical and biotechnology industries, participate in multicentre clinical trials and develop innovative technologies with commercialisation potential.
The University actively expands partnerships with leading academic centres worldwide through joint research projects, mobility programmes and international research infrastructures.
Supporting researchers at every career stage
Building scientific excellence requires investment in people.
WMU provides comprehensive support for researchers through:
- Academy of Young Scientists
- internal grant programmes and nano-grants
- international mobility schemes
- research data management support
- training in grant acquisition, commercialisation and research integrity.
As a recipient of the HR Excellence in Research award, the University promotes transparent recruitment, equal opportunities, responsible research assessment and a supportive research environment aligned with the principles of the European Charter for Researchers.
Research with global impact
Research at Wroclaw Medical University contributes not only to scientific advancement but also to better healthcare, innovation and sustainable development.
By integrating basic science, clinical medicine, translational research and international collaboration, we aim to generate knowledge that improves patients’ lives, informs healthcare policy and strengthens the global biomedical research community.
